nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—ABCB1—hematologic cancer	0.125	1	CbGaD
Epinastine—CYP2B6—Thiotepa—hematologic cancer	0.0425	0.0675	CbGbCtD
Epinastine—ABCB1—Lenalidomide—hematologic cancer	0.0263	0.0418	CbGbCtD
Epinastine—CYP2B6—Ifosfamide—hematologic cancer	0.0241	0.0383	CbGbCtD
Epinastine—CYP2D6—Lomustine—hematologic cancer	0.023	0.0366	CbGbCtD
Epinastine—CYP2B6—Nilotinib—hematologic cancer	0.0209	0.0332	CbGbCtD
Epinastine—CYP2D6—Idarubicin—hematologic cancer	0.0205	0.0326	CbGbCtD
Epinastine—CYP2D6—Hydroxyurea—hematologic cancer	0.0174	0.0277	CbGbCtD
Epinastine—CYP3A4—Bexarotene—hematologic cancer	0.0157	0.025	CbGbCtD
Epinastine—ABCB1—Daunorubicin—hematologic cancer	0.0154	0.0245	CbGbCtD
Epinastine—CYP2D6—Bortezomib—hematologic cancer	0.0152	0.0241	CbGbCtD
Epinastine—ABCB1—Alitretinoin—hematologic cancer	0.0151	0.024	CbGbCtD
Epinastine—CYP3A4—Busulfan—hematologic cancer	0.0146	0.0233	CbGbCtD
Epinastine—CYP3A4—Lomustine—hematologic cancer	0.0146	0.0233	CbGbCtD
Epinastine—CYP2B6—Irinotecan—hematologic cancer	0.0144	0.0228	CbGbCtD
Epinastine—CYP3A4—Thiotepa—hematologic cancer	0.013	0.0207	CbGbCtD
Epinastine—ABCB1—Imatinib—hematologic cancer	0.0118	0.0188	CbGbCtD
Epinastine—CYP2B6—Cisplatin—hematologic cancer	0.0117	0.0186	CbGbCtD
Epinastine—CYP2D6—Imatinib—hematologic cancer	0.0111	0.0177	CbGbCtD
Epinastine—ABCB1—Nilotinib—hematologic cancer	0.0107	0.017	CbGbCtD
Epinastine—ABCB1—Vinorelbine—hematologic cancer	0.0106	0.0169	CbGbCtD
Epinastine—CYP3A4—Methoxsalen—hematologic cancer	0.0101	0.0161	CbGbCtD
Epinastine—CYP2D6—Nilotinib—hematologic cancer	0.0101	0.0161	CbGbCtD
Epinastine—CYP2D6—Vinorelbine—hematologic cancer	0.01	0.0159	CbGbCtD
Epinastine—CYP3A4—Bortezomib—hematologic cancer	0.00965	0.0153	CbGbCtD
Epinastine—ABCB1—Dasatinib—hematologic cancer	0.00948	0.0151	CbGbCtD
Epinastine—CYP2B6—Dexamethasone—hematologic cancer	0.00947	0.015	CbGbCtD
Epinastine—ABCB1—Mitoxantrone—hematologic cancer	0.00936	0.0149	CbGbCtD
Epinastine—CYP3A4—Daunorubicin—hematologic cancer	0.00923	0.0147	CbGbCtD
Epinastine—ABCB1—Betamethasone—hematologic cancer	0.00835	0.0133	CbGbCtD
Epinastine—ABCB1—Gemcitabine—hematologic cancer	0.00827	0.0131	CbGbCtD
Epinastine—ABCB1—Prednisolone—hematologic cancer	0.00823	0.0131	CbGbCtD
Epinastine—CYP3A4—Cytarabine—hematologic cancer	0.00814	0.0129	CbGbCtD
Epinastine—CYP3A4—Teniposide—hematologic cancer	0.00802	0.0127	CbGbCtD
Epinastine—CYP2B6—Doxorubicin—hematologic cancer	0.00786	0.0125	CbGbCtD
Epinastine—ABCB1—Prednisone—hematologic cancer	0.00778	0.0124	CbGbCtD
Epinastine—CYP3A4—Ifosfamide—hematologic cancer	0.0074	0.0118	CbGbCtD
Epinastine—ABCB1—Irinotecan—hematologic cancer	0.00737	0.0117	CbGbCtD
Epinastine—CYP3A4—Imatinib—hematologic cancer	0.00707	0.0112	CbGbCtD
Epinastine—CYP3A4—Ruxolitinib—hematologic cancer	0.00666	0.0106	CbGbCtD
Epinastine—ABCB1—Vinblastine—hematologic cancer	0.00655	0.0104	CbGbCtD
Epinastine—ABCB1—Vincristine—hematologic cancer	0.00644	0.0102	CbGbCtD
Epinastine—CYP3A4—Nilotinib—hematologic cancer	0.00643	0.0102	CbGbCtD
Epinastine—CYP3A4—Vinorelbine—hematologic cancer	0.00637	0.0101	CbGbCtD
Epinastine—CYP2D6—Vinblastine—hematologic cancer	0.00618	0.00981	CbGbCtD
Epinastine—ABCB1—Cisplatin—hematologic cancer	0.00601	0.00955	CbGbCtD
Epinastine—ABCB1—Etoposide—hematologic cancer	0.0059	0.00938	CbGbCtD
Epinastine—CYP3A4—Triamcinolone—hematologic cancer	0.00583	0.00926	CbGbCtD
Epinastine—CYP3A4—Dasatinib—hematologic cancer	0.00568	0.00903	CbGbCtD
Epinastine—CYP3A4—Mitoxantrone—hematologic cancer	0.00561	0.00891	CbGbCtD
Epinastine—CYP3A4—Betamethasone—hematologic cancer	0.005	0.00795	CbGbCtD
Epinastine—CYP3A4—Prednisolone—hematologic cancer	0.00493	0.00784	CbGbCtD
Epinastine—ABCB1—Dexamethasone—hematologic cancer	0.00485	0.00771	CbGbCtD
Epinastine—CYP3A4—Prednisone—hematologic cancer	0.00466	0.0074	CbGbCtD
Epinastine—CYP2D6—Dexamethasone—hematologic cancer	0.00457	0.00727	CbGbCtD
Epinastine—CYP3A4—Irinotecan—hematologic cancer	0.00442	0.00702	CbGbCtD
Epinastine—ABCB1—Doxorubicin—hematologic cancer	0.00403	0.0064	CbGbCtD
Epinastine—CYP3A4—Vinblastine—hematologic cancer	0.00393	0.00624	CbGbCtD
Epinastine—ABCB1—Methotrexate—hematologic cancer	0.0039	0.0062	CbGbCtD
Epinastine—CYP3A4—Vincristine—hematologic cancer	0.00386	0.00613	CbGbCtD
Epinastine—CYP2D6—Doxorubicin—hematologic cancer	0.00379	0.00603	CbGbCtD
Epinastine—CYP3A4—Etoposide—hematologic cancer	0.00354	0.00562	CbGbCtD
Epinastine—CYP3A4—Dexamethasone—hematologic cancer	0.00291	0.00462	CbGbCtD
Epinastine—Hyperaemia—Carmustine—hematologic cancer	0.00288	0.0219	CcSEcCtD
Epinastine—CYP3A4—Doxorubicin—hematologic cancer	0.00241	0.00383	CbGbCtD
Epinastine—HRH2—hematopoietic system—hematologic cancer	0.00221	0.0814	CbGeAlD
Epinastine—Hyperaemia—Dexamethasone—hematologic cancer	0.00183	0.014	CcSEcCtD
Epinastine—Hyperaemia—Betamethasone—hematologic cancer	0.00183	0.014	CcSEcCtD
Epinastine—Cough increased—Pentostatin—hematologic cancer	0.0018	0.0137	CcSEcCtD
Epinastine—Lacrimation increased—Pentostatin—hematologic cancer	0.00179	0.0136	CcSEcCtD
Epinastine—Cough increased—Bexarotene—hematologic cancer	0.00149	0.0113	CcSEcCtD
Epinastine—Eye irritation—Nilotinib—hematologic cancer	0.00147	0.0112	CcSEcCtD
Epinastine—Eye irritation—Imatinib—hematologic cancer	0.00146	0.0112	CcSEcCtD
Epinastine—HRH2—blood—hematologic cancer	0.00146	0.0539	CbGeAlD
Epinastine—Upper respiratory tract infection—Vorinostat—hematologic cancer	0.00142	0.0108	CcSEcCtD
Epinastine—Lacrimation increased—Imatinib—hematologic cancer	0.00136	0.0103	CcSEcCtD
Epinastine—HRH2—lung—hematologic cancer	0.00128	0.0473	CbGeAlD
Epinastine—Eye irritation—Lenalidomide—hematologic cancer	0.00128	0.00973	CcSEcCtD
Epinastine—Eye irritation—Bortezomib—hematologic cancer	0.00117	0.00896	CcSEcCtD
Epinastine—HTR7—hematopoietic system—hematologic cancer	0.00112	0.0414	CbGeAlD
Epinastine—Lacrimation increased—Bortezomib—hematologic cancer	0.00109	0.0083	CcSEcCtD
Epinastine—ADRA1A—hematopoietic system—hematologic cancer	0.00108	0.0399	CbGeAlD
Epinastine—Infection—Ruxolitinib—hematologic cancer	0.00102	0.0078	CcSEcCtD
Epinastine—Eye irritation—Alitretinoin—hematologic cancer	0.00101	0.00769	CcSEcCtD
Epinastine—Eye irritation—Ifosfamide—hematologic cancer	0.000996	0.0076	CcSEcCtD
Epinastine—Upper respiratory tract infection—Clofarabine—hematologic cancer	0.000964	0.00735	CcSEcCtD
Epinastine—Upper respiratory tract infection—Pentostatin—hematologic cancer	0.00096	0.00732	CcSEcCtD
Epinastine—Lacrimation increased—Alitretinoin—hematologic cancer	0.000934	0.00712	CcSEcCtD
Epinastine—Cough—Vorinostat—hematologic cancer	0.00093	0.0071	CcSEcCtD
Epinastine—Sinusitis—Nelarabine—hematologic cancer	0.000927	0.00707	CcSEcCtD
Epinastine—Cough increased—Irinotecan—hematologic cancer	0.000882	0.00673	CcSEcCtD
Epinastine—HRH2—lymph node—hematologic cancer	0.000877	0.0323	CbGeAlD
Epinastine—Lacrimation increased—Irinotecan—hematologic cancer	0.000876	0.00668	CcSEcCtD
Epinastine—Sinusitis—Clofarabine—hematologic cancer	0.000868	0.00662	CcSEcCtD
Epinastine—Sinusitis—Daunorubicin—hematologic cancer	0.000868	0.00662	CcSEcCtD
Epinastine—Infection—Vorinostat—hematologic cancer	0.000864	0.00659	CcSEcCtD
Epinastine—Sinusitis—Pentostatin—hematologic cancer	0.000864	0.00659	CcSEcCtD
Epinastine—Sinusitis—Anagrelide—hematologic cancer	0.000864	0.00659	CcSEcCtD
Epinastine—CYP2B6—hematopoietic system—hematologic cancer	0.000858	0.0317	CbGeAlD
Epinastine—HTR7—gonad—hematologic cancer	0.000854	0.0315	CbGeAlD
Epinastine—HRH1—hematopoietic system—hematologic cancer	0.000838	0.0309	CbGeAlD
Epinastine—Rhinitis—Daunorubicin—hematologic cancer	0.000832	0.00635	CcSEcCtD
Epinastine—Rhinitis—Anagrelide—hematologic cancer	0.000829	0.00632	CcSEcCtD
Epinastine—Rhinitis—Pentostatin—hematologic cancer	0.000829	0.00632	CcSEcCtD
Epinastine—ADRA2A—hematopoietic system—hematologic cancer	0.000823	0.0304	CbGeAlD
Epinastine—Pharyngitis—Pentostatin—hematologic cancer	0.00082	0.00626	CcSEcCtD
Epinastine—Pharyngitis—Anagrelide—hematologic cancer	0.00082	0.00626	CcSEcCtD
Epinastine—Nasopharyngitis—Nilotinib—hematologic cancer	0.000816	0.00623	CcSEcCtD
Epinastine—Nasopharyngitis—Imatinib—hematologic cancer	0.000811	0.00619	CcSEcCtD
Epinastine—Upper respiratory tract infection—Dasatinib—hematologic cancer	0.000793	0.00605	CcSEcCtD
Epinastine—Upper respiratory tract infection—Fludarabine—hematologic cancer	0.000791	0.00604	CcSEcCtD
Epinastine—Eye irritation—Prednisolone—hematologic cancer	0.000776	0.00592	CcSEcCtD
Epinastine—Infection—Lomustine—hematologic cancer	0.000775	0.00591	CcSEcCtD
Epinastine—Sinusitis—Busulfan—hematologic cancer	0.000751	0.00573	CcSEcCtD
Epinastine—HTR7—blood—hematologic cancer	0.000744	0.0274	CbGeAlD
Epinastine—Infection—Mechlorethamine—hematologic cancer	0.000742	0.00566	CcSEcCtD
Epinastine—Upper respiratory tract infection—Nilotinib—hematologic cancer	0.000733	0.00559	CcSEcCtD
Epinastine—Upper respiratory tract infection—Imatinib—hematologic cancer	0.000729	0.00556	CcSEcCtD
Epinastine—Pruritus—Ruxolitinib—hematologic cancer	0.000728	0.00555	CcSEcCtD
Epinastine—Rhinitis—Busulfan—hematologic cancer	0.00072	0.00549	CcSEcCtD
Epinastine—ADRA1A—blood—hematologic cancer	0.000717	0.0265	CbGeAlD
Epinastine—Upper respiratory tract infection—Cladribine—hematologic cancer	0.000716	0.00546	CcSEcCtD
Epinastine—Sinusitis—Bexarotene—hematologic cancer	0.000714	0.00545	CcSEcCtD
Epinastine—Pharyngitis—Busulfan—hematologic cancer	0.000713	0.00544	CcSEcCtD
Epinastine—Sinusitis—Fludarabine—hematologic cancer	0.000712	0.00543	CcSEcCtD
Epinastine—Nasopharyngitis—Lenalidomide—hematologic cancer	0.000707	0.00539	CcSEcCtD
Epinastine—HTR2A—hematopoietic system—hematologic cancer	0.0007	0.0258	CbGeAlD
Epinastine—Rhinitis—Bexarotene—hematologic cancer	0.000685	0.00523	CcSEcCtD
Epinastine—Pharyngitis—Bexarotene—hematologic cancer	0.000678	0.00517	CcSEcCtD
Epinastine—Pharyngitis—Fludarabine—hematologic cancer	0.000676	0.00516	CcSEcCtD
Epinastine—Cough—Nelarabine—hematologic cancer	0.000674	0.00514	CcSEcCtD
Epinastine—Cough increased—Triamcinolone—hematologic cancer	0.000665	0.00508	CcSEcCtD
Epinastine—Sinusitis—Imatinib—hematologic cancer	0.000656	0.005	CcSEcCtD
Epinastine—CYP2B6—gonad—hematologic cancer	0.000653	0.0241	CbGeAlD
Epinastine—HTR7—lung—hematologic cancer	0.000652	0.024	CbGeAlD
Epinastine—Nasopharyngitis—Bortezomib—hematologic cancer	0.000651	0.00496	CcSEcCtD
Epinastine—CYP3A4—hematopoietic system—hematologic cancer	0.000648	0.0239	CbGeAlD
Epinastine—Headache—Ruxolitinib—hematologic cancer	0.000645	0.00492	CcSEcCtD
Epinastine—CYP2D6—hematopoietic system—hematologic cancer	0.000638	0.0235	CbGeAlD
Epinastine—Upper respiratory tract infection—Lenalidomide—hematologic cancer	0.000635	0.00485	CcSEcCtD
Epinastine—Rhinitis—Nilotinib—hematologic cancer	0.000633	0.00483	CcSEcCtD
Epinastine—Cough—Clofarabine—hematologic cancer	0.000631	0.00481	CcSEcCtD
Epinastine—Cough—Daunorubicin—hematologic cancer	0.000631	0.00481	CcSEcCtD
Epinastine—Rhinitis—Imatinib—hematologic cancer	0.000629	0.0048	CcSEcCtD
Epinastine—Cough—Pentostatin—hematologic cancer	0.000628	0.00479	CcSEcCtD
Epinastine—Cough—Anagrelide—hematologic cancer	0.000628	0.00479	CcSEcCtD
Epinastine—Pharyngitis—Nilotinib—hematologic cancer	0.000627	0.00478	CcSEcCtD
Epinastine—Infection—Nelarabine—hematologic cancer	0.000626	0.00478	CcSEcCtD
Epinastine—ADRA2A—gonad—hematologic cancer	0.000626	0.0231	CbGeAlD
Epinastine—Pharyngitis—Imatinib—hematologic cancer	0.000623	0.00475	CcSEcCtD
Epinastine—Pruritus—Vorinostat—hematologic cancer	0.000615	0.00469	CcSEcCtD
Epinastine—HTR7—testis—hematologic cancer	0.000615	0.0227	CbGeAlD
Epinastine—Pharyngitis—Cladribine—hematologic cancer	0.000612	0.00467	CcSEcCtD
Epinastine—Infection—Methoxsalen—hematologic cancer	0.000612	0.00467	CcSEcCtD
Epinastine—Pharyngitis—Vinblastine—hematologic cancer	0.000587	0.00448	CcSEcCtD
Epinastine—Infection—Clofarabine—hematologic cancer	0.000586	0.00447	CcSEcCtD
Epinastine—Infection—Daunorubicin—hematologic cancer	0.000586	0.00447	CcSEcCtD
Epinastine—Upper respiratory tract infection—Bortezomib—hematologic cancer	0.000585	0.00446	CcSEcCtD
Epinastine—Infection—Anagrelide—hematologic cancer	0.000583	0.00445	CcSEcCtD
Epinastine—Infection—Pentostatin—hematologic cancer	0.000583	0.00445	CcSEcCtD
Epinastine—Sinusitis—Lenalidomide—hematologic cancer	0.000572	0.00436	CcSEcCtD
Epinastine—CYP2B6—blood—hematologic cancer	0.000569	0.021	CbGeAlD
Epinastine—Infection—Idarubicin—hematologic cancer	0.000563	0.00429	CcSEcCtD
Epinastine—Nasopharyngitis—Alitretinoin—hematologic cancer	0.000558	0.00426	CcSEcCtD
Epinastine—Rhinitis—Lenalidomide—hematologic cancer	0.000549	0.00418	CcSEcCtD
Epinastine—Infection—Teniposide—hematologic cancer	0.000547	0.00417	CcSEcCtD
Epinastine—Cough—Busulfan—hematologic cancer	0.000546	0.00416	CcSEcCtD
Epinastine—ADRA2A—blood—hematologic cancer	0.000545	0.0201	CbGeAlD
Epinastine—Headache—Vorinostat—hematologic cancer	0.000545	0.00416	CcSEcCtD
Epinastine—Pharyngitis—Lenalidomide—hematologic cancer	0.000543	0.00414	CcSEcCtD
Epinastine—HTR2A—gonad—hematologic cancer	0.000532	0.0196	CbGeAlD
Epinastine—Cough—Procarbazine—hematologic cancer	0.00053	0.00404	CcSEcCtD
Epinastine—Pruritus—Mechlorethamine—hematologic cancer	0.000529	0.00403	CcSEcCtD
Epinastine—Upper respiratory tract infection—Thalidomide—hematologic cancer	0.000527	0.00402	CcSEcCtD
Epinastine—Sinusitis—Bortezomib—hematologic cancer	0.000526	0.00401	CcSEcCtD
Epinastine—Cough—Bexarotene—hematologic cancer	0.000519	0.00396	CcSEcCtD
Epinastine—Cough—Dasatinib—hematologic cancer	0.000519	0.00396	CcSEcCtD
Epinastine—Cough—Fludarabine—hematologic cancer	0.000518	0.00395	CcSEcCtD
Epinastine—Infection—Busulfan—hematologic cancer	0.000507	0.00387	CcSEcCtD
Epinastine—Upper respiratory tract infection—Alitretinoin—hematologic cancer	0.000502	0.00383	CcSEcCtD
Epinastine—CYP2B6—lung—hematologic cancer	0.000498	0.0184	CbGeAlD
Epinastine—Infection—Procarbazine—hematologic cancer	0.000492	0.00375	CcSEcCtD
Epinastine—HRH1—lung—hematologic cancer	0.000487	0.018	CbGeAlD
Epinastine—Infection—Bexarotene—hematologic cancer	0.000482	0.00368	CcSEcCtD
Epinastine—Infection—Dasatinib—hematologic cancer	0.000482	0.00368	CcSEcCtD
Epinastine—Infection—Fludarabine—hematologic cancer	0.000481	0.00367	CcSEcCtD
Epinastine—Cough—Nilotinib—hematologic cancer	0.00048	0.00366	CcSEcCtD
Epinastine—ADRA2A—lung—hematologic cancer	0.000478	0.0176	CbGeAlD
Epinastine—Cough—Imatinib—hematologic cancer	0.000477	0.00364	CcSEcCtD
Epinastine—Nasopharyngitis—Cisplatin—hematologic cancer	0.000476	0.00363	CcSEcCtD
Epinastine—Sinusitis—Thalidomide—hematologic cancer	0.000475	0.00362	CcSEcCtD
Epinastine—Upper respiratory tract infection—Irinotecan—hematologic cancer	0.000471	0.00359	CcSEcCtD
Epinastine—Upper respiratory tract infection—Mitoxantrone—hematologic cancer	0.000471	0.00359	CcSEcCtD
Epinastine—CYP2B6—testis—hematologic cancer	0.00047	0.0173	CbGeAlD
Epinastine—Cough—Cladribine—hematologic cancer	0.000469	0.00357	CcSEcCtD
Epinastine—HTR2A—blood—hematologic cancer	0.000464	0.0171	CbGeAlD
Epinastine—HRH1—testis—hematologic cancer	0.000459	0.0169	CbGeAlD
Epinastine—ABCB1—hematopoietic system—hematologic cancer	0.000459	0.0169	CbGeAlD
Epinastine—Infection—Chlorambucil—hematologic cancer	0.000456	0.00348	CcSEcCtD
Epinastine—Rhinitis—Thalidomide—hematologic cancer	0.000455	0.00347	CcSEcCtD
Epinastine—Sinusitis—Alitretinoin—hematologic cancer	0.000452	0.00344	CcSEcCtD
Epinastine—ADRA2A—testis—hematologic cancer	0.000451	0.0166	CbGeAlD
Epinastine—Pharyngitis—Thalidomide—hematologic cancer	0.000451	0.00344	CcSEcCtD
Epinastine—Infection—Nilotinib—hematologic cancer	0.000446	0.0034	CcSEcCtD
Epinastine—Infection—Imatinib—hematologic cancer	0.000443	0.00338	CcSEcCtD
Epinastine—Pruritus—Methoxsalen—hematologic cancer	0.000436	0.00332	CcSEcCtD
Epinastine—Infection—Cladribine—hematologic cancer	0.000435	0.00332	CcSEcCtD
Epinastine—CYP3A4—blood—hematologic cancer	0.000429	0.0158	CbGeAlD
Epinastine—Pharyngitis—Alitretinoin—hematologic cancer	0.000429	0.00327	CcSEcCtD
Epinastine—Cough—Melphalan—hematologic cancer	0.000427	0.00326	CcSEcCtD
Epinastine—Sinusitis—Mitoxantrone—hematologic cancer	0.000424	0.00323	CcSEcCtD
Epinastine—CYP2D6—blood—hematologic cancer	0.000423	0.0156	CbGeAlD
Epinastine—Pruritus—Daunorubicin—hematologic cancer	0.000417	0.00318	CcSEcCtD
Epinastine—Pruritus—Clofarabine—hematologic cancer	0.000417	0.00318	CcSEcCtD
Epinastine—Cough—Lenalidomide—hematologic cancer	0.000416	0.00317	CcSEcCtD
Epinastine—Pruritus—Anagrelide—hematologic cancer	0.000415	0.00317	CcSEcCtD
Epinastine—Pruritus—Pentostatin—hematologic cancer	0.000415	0.00317	CcSEcCtD
Epinastine—Cough increased—Epirubicin—hematologic cancer	0.000411	0.00314	CcSEcCtD
Epinastine—Lacrimation increased—Epirubicin—hematologic cancer	0.000408	0.00312	CcSEcCtD
Epinastine—HTR2A—lung—hematologic cancer	0.000407	0.015	CbGeAlD
Epinastine—Rhinitis—Mitoxantrone—hematologic cancer	0.000406	0.0031	CcSEcCtD
Epinastine—Rhinitis—Irinotecan—hematologic cancer	0.000406	0.0031	CcSEcCtD
Epinastine—Pharyngitis—Mitoxantrone—hematologic cancer	0.000402	0.00307	CcSEcCtD
Epinastine—Infection—Melphalan—hematologic cancer	0.000397	0.00303	CcSEcCtD
Epinastine—Rhinitis—Gemcitabine—hematologic cancer	0.000396	0.00302	CcSEcCtD
Epinastine—Headache—Nelarabine—hematologic cancer	0.000395	0.00301	CcSEcCtD
Epinastine—Pharyngitis—Gemcitabine—hematologic cancer	0.000392	0.00299	CcSEcCtD
Epinastine—Pruritus—Teniposide—hematologic cancer	0.00039	0.00297	CcSEcCtD
Epinastine—Infection—Lenalidomide—hematologic cancer	0.000386	0.00295	CcSEcCtD
Epinastine—Headache—Methoxsalen—hematologic cancer	0.000386	0.00294	CcSEcCtD
Epinastine—HTR2A—testis—hematologic cancer	0.000384	0.0141	CbGeAlD
Epinastine—Cough—Bortezomib—hematologic cancer	0.000382	0.00292	CcSEcCtD
Epinastine—Infection—Hydroxyurea—hematologic cancer	0.000381	0.0029	CcSEcCtD
Epinastine—Cough increased—Doxorubicin—hematologic cancer	0.00038	0.0029	CcSEcCtD
Epinastine—Cough—Bleomycin—hematologic cancer	0.00038	0.0029	CcSEcCtD
Epinastine—Lacrimation increased—Doxorubicin—hematologic cancer	0.000378	0.00288	CcSEcCtD
Epinastine—Cough—Vinorelbine—hematologic cancer	0.000373	0.00285	CcSEcCtD
Epinastine—Headache—Clofarabine—hematologic cancer	0.00037	0.00282	CcSEcCtD
Epinastine—Headache—Daunorubicin—hematologic cancer	0.00037	0.00282	CcSEcCtD
Epinastine—Headache—Pentostatin—hematologic cancer	0.000368	0.00281	CcSEcCtD
Epinastine—Headache—Anagrelide—hematologic cancer	0.000368	0.00281	CcSEcCtD
Epinastine—Pruritus—Busulfan—hematologic cancer	0.000361	0.00276	CcSEcCtD
Epinastine—Cough—Thiotepa—hematologic cancer	0.000357	0.00272	CcSEcCtD
Epinastine—Infection—Bortezomib—hematologic cancer	0.000355	0.00271	CcSEcCtD
Epinastine—Upper respiratory tract infection—Triamcinolone—hematologic cancer	0.000355	0.00271	CcSEcCtD
Epinastine—Headache—Idarubicin—hematologic cancer	0.000355	0.00271	CcSEcCtD
Epinastine—Infection—Bleomycin—hematologic cancer	0.000353	0.00269	CcSEcCtD
Epinastine—Pruritus—Procarbazine—hematologic cancer	0.00035	0.00267	CcSEcCtD
Epinastine—CYP2D6—testis—hematologic cancer	0.000349	0.0129	CbGeAlD
Epinastine—ABCB1—gonad—hematologic cancer	0.000349	0.0129	CbGeAlD
Epinastine—Infection—Vinorelbine—hematologic cancer	0.000347	0.00265	CcSEcCtD
Epinastine—Headache—Teniposide—hematologic cancer	0.000345	0.00263	CcSEcCtD
Epinastine—Cough—Thalidomide—hematologic cancer	0.000345	0.00263	CcSEcCtD
Epinastine—Pruritus—Bexarotene—hematologic cancer	0.000343	0.00262	CcSEcCtD
Epinastine—Pruritus—Dasatinib—hematologic cancer	0.000343	0.00262	CcSEcCtD
Epinastine—Pruritus—Fludarabine—hematologic cancer	0.000343	0.00261	CcSEcCtD
Epinastine—HRH1—lymph node—hematologic cancer	0.000333	0.0123	CbGeAlD
Epinastine—Infection—Thiotepa—hematologic cancer	0.000331	0.00253	CcSEcCtD
Epinastine—Cough—Alitretinoin—hematologic cancer	0.000328	0.0025	CcSEcCtD
Epinastine—ADRA2A—lymph node—hematologic cancer	0.000327	0.0121	CbGeAlD
Epinastine—Pruritus—Chlorambucil—hematologic cancer	0.000324	0.00248	CcSEcCtD
Epinastine—Cough—Ifosfamide—hematologic cancer	0.000324	0.00247	CcSEcCtD
Epinastine—Infection—Thalidomide—hematologic cancer	0.00032	0.00244	CcSEcCtD
Epinastine—Headache—Busulfan—hematologic cancer	0.00032	0.00244	CcSEcCtD
Epinastine—Pruritus—Nilotinib—hematologic cancer	0.000317	0.00242	CcSEcCtD
Epinastine—Pruritus—Imatinib—hematologic cancer	0.000316	0.00241	CcSEcCtD
Epinastine—Headache—Procarbazine—hematologic cancer	0.00031	0.00237	CcSEcCtD
Epinastine—Pruritus—Cladribine—hematologic cancer	0.00031	0.00237	CcSEcCtD
Epinastine—Cough—Mitoxantrone—hematologic cancer	0.000308	0.00235	CcSEcCtD
Epinastine—Cough—Irinotecan—hematologic cancer	0.000308	0.00235	CcSEcCtD
Epinastine—Infection—Carmustine—hematologic cancer	0.000308	0.00235	CcSEcCtD
Epinastine—Rhinitis—Triamcinolone—hematologic cancer	0.000307	0.00234	CcSEcCtD
Epinastine—Infection—Alitretinoin—hematologic cancer	0.000305	0.00233	CcSEcCtD
Epinastine—Headache—Bexarotene—hematologic cancer	0.000304	0.00232	CcSEcCtD
Epinastine—Headache—Dasatinib—hematologic cancer	0.000304	0.00232	CcSEcCtD
Epinastine—ABCB1—blood—hematologic cancer	0.000304	0.0112	CbGeAlD
Epinastine—Pharyngitis—Triamcinolone—hematologic cancer	0.000304	0.00232	CcSEcCtD
Epinastine—Headache—Fludarabine—hematologic cancer	0.000303	0.00231	CcSEcCtD
Epinastine—Infection—Ifosfamide—hematologic cancer	0.000301	0.0023	CcSEcCtD
Epinastine—Cough—Gemcitabine—hematologic cancer	0.0003	0.00229	CcSEcCtD
Epinastine—ABCB1—bone marrow—hematologic cancer	0.000294	0.0108	CbGeAlD
Epinastine—Infection—Vincristine—hematologic cancer	0.000294	0.00224	CcSEcCtD
Epinastine—Infection—Irinotecan—hematologic cancer	0.000286	0.00218	CcSEcCtD
Epinastine—Infection—Mitoxantrone—hematologic cancer	0.000286	0.00218	CcSEcCtD
Epinastine—Pruritus—Melphalan—hematologic cancer	0.000283	0.00216	CcSEcCtD
Epinastine—Headache—Nilotinib—hematologic cancer	0.000281	0.00214	CcSEcCtD
Epinastine—Headache—Imatinib—hematologic cancer	0.000279	0.00213	CcSEcCtD
Epinastine—Infection—Gemcitabine—hematologic cancer	0.000279	0.00213	CcSEcCtD
Epinastine—Pruritus—Lenalidomide—hematologic cancer	0.000275	0.0021	CcSEcCtD
Epinastine—Headache—Cladribine—hematologic cancer	0.000275	0.00209	CcSEcCtD
Epinastine—ABCB1—lung—hematologic cancer	0.000266	0.00983	CbGeAlD
Epinastine—Headache—Vinblastine—hematologic cancer	0.000263	0.00201	CcSEcCtD
Epinastine—Infection—Cisplatin—hematologic cancer	0.00026	0.00198	CcSEcCtD
Epinastine—Cough—Etoposide—hematologic cancer	0.000256	0.00195	CcSEcCtD
Epinastine—Pruritus—Bortezomib—hematologic cancer	0.000253	0.00193	CcSEcCtD
Epinastine—ABCB1—testis—hematologic cancer	0.000251	0.00927	CbGeAlD
Epinastine—Pruritus—Bleomycin—hematologic cancer	0.000251	0.00192	CcSEcCtD
Epinastine—Pruritus—Vinorelbine—hematologic cancer	0.000247	0.00188	CcSEcCtD
Epinastine—Nasopharyngitis—Epirubicin—hematologic cancer	0.000244	0.00186	CcSEcCtD
Epinastine—Headache—Lenalidomide—hematologic cancer	0.000244	0.00186	CcSEcCtD
Epinastine—Headache—Hydroxyurea—hematologic cancer	0.00024	0.00183	CcSEcCtD
Epinastine—Infection—Etoposide—hematologic cancer	0.000238	0.00182	CcSEcCtD
Epinastine—Pruritus—Thiotepa—hematologic cancer	0.000236	0.0018	CcSEcCtD
Epinastine—Upper respiratory tract infection—Methotrexate—hematologic cancer	0.000235	0.00179	CcSEcCtD
Epinastine—Cough—Triamcinolone—hematologic cancer	0.000232	0.00177	CcSEcCtD
Epinastine—Pruritus—Thalidomide—hematologic cancer	0.000228	0.00174	CcSEcCtD
Epinastine—Nasopharyngitis—Doxorubicin—hematologic cancer	0.000226	0.00172	CcSEcCtD
Epinastine—Headache—Bortezomib—hematologic cancer	0.000224	0.00171	CcSEcCtD
Epinastine—Upper respiratory tract infection—Epirubicin—hematologic cancer	0.000219	0.00167	CcSEcCtD
Epinastine—Headache—Vinorelbine—hematologic cancer	0.000219	0.00167	CcSEcCtD
Epinastine—Pruritus—Alitretinoin—hematologic cancer	0.000217	0.00166	CcSEcCtD
Epinastine—Infection—Triamcinolone—hematologic cancer	0.000216	0.00165	CcSEcCtD
Epinastine—Pruritus—Ifosfamide—hematologic cancer	0.000215	0.00164	CcSEcCtD
Epinastine—Headache—Thiotepa—hematologic cancer	0.000209	0.00159	CcSEcCtD
Epinastine—Upper respiratory tract infection—Doxorubicin—hematologic cancer	0.000203	0.00155	CcSEcCtD
Epinastine—Headache—Thalidomide—hematologic cancer	0.000202	0.00154	CcSEcCtD
Epinastine—Pharyngitis—Methotrexate—hematologic cancer	0.0002	0.00153	CcSEcCtD
Epinastine—Pruritus—Gemcitabine—hematologic cancer	0.000199	0.00151	CcSEcCtD
Epinastine—Sinusitis—Epirubicin—hematologic cancer	0.000198	0.00151	CcSEcCtD
Epinastine—Infection—Betamethasone—hematologic cancer	0.000196	0.00149	CcSEcCtD
Epinastine—Infection—Dexamethasone—hematologic cancer	0.000196	0.00149	CcSEcCtD
Epinastine—Headache—Carmustine—hematologic cancer	0.000194	0.00148	CcSEcCtD
Epinastine—Headache—Alitretinoin—hematologic cancer	0.000192	0.00147	CcSEcCtD
Epinastine—Rhinitis—Epirubicin—hematologic cancer	0.00019	0.00145	CcSEcCtD
Epinastine—Pharyngitis—Epirubicin—hematologic cancer	0.000188	0.00143	CcSEcCtD
Epinastine—Headache—Vincristine—hematologic cancer	0.000185	0.00141	CcSEcCtD
Epinastine—Sinusitis—Doxorubicin—hematologic cancer	0.000183	0.00139	CcSEcCtD
Epinastine—ABCB1—lymph node—hematologic cancer	0.000182	0.00672	CbGeAlD
Epinastine—Headache—Irinotecan—hematologic cancer	0.00018	0.00138	CcSEcCtD
Epinastine—Headache—Mitoxantrone—hematologic cancer	0.00018	0.00138	CcSEcCtD
Epinastine—Headache—Gemcitabine—hematologic cancer	0.000176	0.00134	CcSEcCtD
Epinastine—Rhinitis—Doxorubicin—hematologic cancer	0.000175	0.00134	CcSEcCtD
Epinastine—Pharyngitis—Doxorubicin—hematologic cancer	0.000174	0.00132	CcSEcCtD
Epinastine—Infection—Prednisone—hematologic cancer	0.000171	0.0013	CcSEcCtD
Epinastine—Pruritus—Etoposide—hematologic cancer	0.00017	0.00129	CcSEcCtD
Epinastine—Pruritus—Triamcinolone—hematologic cancer	0.000154	0.00117	CcSEcCtD
Epinastine—Cough—Methotrexate—hematologic cancer	0.000153	0.00117	CcSEcCtD
Epinastine—Headache—Etoposide—hematologic cancer	0.00015	0.00114	CcSEcCtD
Epinastine—Headache—Prednisolone—hematologic cancer	0.000148	0.00113	CcSEcCtD
Epinastine—Cough—Epirubicin—hematologic cancer	0.000144	0.0011	CcSEcCtD
Epinastine—Infection—Methotrexate—hematologic cancer	0.000143	0.00109	CcSEcCtD
Epinastine—Pruritus—Betamethasone—hematologic cancer	0.00014	0.00106	CcSEcCtD
Epinastine—Pruritus—Dexamethasone—hematologic cancer	0.00014	0.00106	CcSEcCtD
Epinastine—Headache—Triamcinolone—hematologic cancer	0.000136	0.00104	CcSEcCtD
Epinastine—Infection—Epirubicin—hematologic cancer	0.000133	0.00102	CcSEcCtD
Epinastine—Cough—Doxorubicin—hematologic cancer	0.000133	0.00101	CcSEcCtD
Epinastine—Desipramine—SLC22A1—hematologic cancer	0.000125	0.214	CrCbGaD
Epinastine—Headache—Dexamethasone—hematologic cancer	0.000124	0.000942	CcSEcCtD
Epinastine—Headache—Betamethasone—hematologic cancer	0.000124	0.000942	CcSEcCtD
Epinastine—Infection—Doxorubicin—hematologic cancer	0.000123	0.000942	CcSEcCtD
Epinastine—Pruritus—Prednisone—hematologic cancer	0.000121	0.000927	CcSEcCtD
Epinastine—Headache—Prednisone—hematologic cancer	0.000108	0.000821	CcSEcCtD
Epinastine—Imipramine—SLC22A1—hematologic cancer	0.000106	0.181	CrCbGaD
Epinastine—Pruritus—Methotrexate—hematologic cancer	0.000102	0.000775	CcSEcCtD
Epinastine—Pruritus—Epirubicin—hematologic cancer	9.5e-05	0.000725	CcSEcCtD
Epinastine—Headache—Methotrexate—hematologic cancer	8.99e-05	0.000686	CcSEcCtD
Epinastine—Pruritus—Doxorubicin—hematologic cancer	8.79e-05	0.000671	CcSEcCtD
Epinastine—Headache—Epirubicin—hematologic cancer	8.41e-05	0.000642	CcSEcCtD
Epinastine—Oxcarbazepine—ALB—hematologic cancer	8.25e-05	0.141	CrCbGaD
Epinastine—Headache—Doxorubicin—hematologic cancer	7.78e-05	0.000594	CcSEcCtD
Epinastine—Carbamazepine—ABCB1—hematologic cancer	5.36e-05	0.0917	CrCbGaD
Epinastine—Nortriptyline—ALB—hematologic cancer	4.63e-05	0.0791	CrCbGaD
Epinastine—Trimipramine—ABCB1—hematologic cancer	4.16e-05	0.0711	CrCbGaD
Epinastine—Desipramine—ABCB1—hematologic cancer	3.64e-05	0.0621	CrCbGaD
Epinastine—Amitriptyline—ALB—hematologic cancer	3.21e-05	0.0549	CrCbGaD
Epinastine—Imipramine—ABCB1—hematologic cancer	3.08e-05	0.0527	CrCbGaD
Epinastine—Amitriptyline—ABCB1—hematologic cancer	3.07e-05	0.0524	CrCbGaD
Epinastine—HRH1—Signaling Pathways—CREB1—hematologic cancer	4.41e-06	5.08e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—CREBBP—hematologic cancer	4.39e-06	5.05e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—ALB—hematologic cancer	4.38e-06	5.05e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—BRAF—hematologic cancer	4.36e-06	5.02e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—BAD—hematologic cancer	4.36e-06	5.02e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NFKBIA—hematologic cancer	4.36e-06	5.02e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—BRAF—hematologic cancer	4.35e-06	5.01e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—MAPK3—hematologic cancer	4.35e-06	5.01e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—VEGFA—hematologic cancer	4.33e-06	4.99e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CREB1—hematologic cancer	4.32e-06	4.98e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCL2—hematologic cancer	4.32e-06	4.98e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NOTCH1—hematologic cancer	4.32e-06	4.97e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCL2—hematologic cancer	4.31e-06	4.97e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL6R—hematologic cancer	4.31e-06	4.96e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CREBBP—hematologic cancer	4.3e-06	4.95e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL6R—hematologic cancer	4.3e-06	4.95e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CREBBP—hematologic cancer	4.29e-06	4.94e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—STAT3—hematologic cancer	4.29e-06	4.94e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—NRAS—hematologic cancer	4.28e-06	4.93e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TP53—hematologic cancer	4.27e-06	4.92e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—BRAF—hematologic cancer	4.27e-06	4.92e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCL2—hematologic cancer	4.23e-06	4.87e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CD80—hematologic cancer	4.23e-06	4.87e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—KIT—hematologic cancer	4.22e-06	4.86e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CG—hematologic cancer	4.22e-06	4.86e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—NRAS—hematologic cancer	4.22e-06	4.86e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL6R—hematologic cancer	4.22e-06	4.86e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CREBBP—hematologic cancer	4.21e-06	4.85e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PIK3R1—hematologic cancer	4.19e-06	4.83e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	4.16e-06	4.79e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—MTHFR—hematologic cancer	4.15e-06	4.78e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PTPN11—hematologic cancer	4.15e-06	4.78e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—ALB—hematologic cancer	4.11e-06	4.73e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MAP2K1—hematologic cancer	4.11e-06	4.73e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MAPK3—hematologic cancer	4.1e-06	4.72e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	4.1e-06	4.72e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—HRAS—hematologic cancer	4.09e-06	4.71e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CD—hematologic cancer	4.08e-06	4.7e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	4.07e-06	4.69e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—MAPK3—hematologic cancer	4.04e-06	4.66e-05	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—PIK3CA—hematologic cancer	4.04e-06	4.65e-05	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	4.03e-06	4.64e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MAP2K1—hematologic cancer	4.02e-06	4.63e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CREB1—hematologic cancer	4.02e-06	4.63e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CD—hematologic cancer	3.99e-06	4.6e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—KRAS—hematologic cancer	3.99e-06	4.6e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MYC—hematologic cancer	3.99e-06	4.59e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—KRAS—hematologic cancer	3.98e-06	4.59e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TGFB1—hematologic cancer	3.98e-06	4.58e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—BRAF—hematologic cancer	3.97e-06	4.57e-05	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—PIK3CA—hematologic cancer	3.96e-06	4.56e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCL2—hematologic cancer	3.93e-06	4.53e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	3.93e-06	4.52e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL6R—hematologic cancer	3.92e-06	4.51e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.91e-06	4.51e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CREBBP—hematologic cancer	3.91e-06	4.51e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IL6—hematologic cancer	3.91e-06	4.51e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—KRAS—hematologic cancer	3.91e-06	4.5e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—FGF2—hematologic cancer	3.91e-06	4.5e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—FGF2—hematologic cancer	3.9e-06	4.49e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PIK3CB—hematologic cancer	3.87e-06	4.45e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3R1—hematologic cancer	3.85e-06	4.44e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	3.84e-06	4.43e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—FGF2—hematologic cancer	3.82e-06	4.4e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NQO1—hematologic cancer	3.78e-06	4.35e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CD44—hematologic cancer	3.78e-06	4.35e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3R1—hematologic cancer	3.77e-06	4.34e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—JAK2—hematologic cancer	3.74e-06	4.31e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MAP2K1—hematologic cancer	3.74e-06	4.3e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—JAK2—hematologic cancer	3.73e-06	4.3e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CD—hematologic cancer	3.71e-06	4.27e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—KRAS—hematologic cancer	3.68e-06	4.24e-05	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—PIK3CA—hematologic cancer	3.68e-06	4.23e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—PIK3CA—hematologic cancer	3.67e-06	4.23e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—JAK2—hematologic cancer	3.67e-06	4.22e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	3.66e-06	4.22e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MDM2—hematologic cancer	3.65e-06	4.21e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MDM2—hematologic cancer	3.65e-06	4.2e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—KRAS—hematologic cancer	3.63e-06	4.18e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	3.63e-06	4.18e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—AKT1—hematologic cancer	3.61e-06	4.16e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—PIK3CA—hematologic cancer	3.59e-06	4.14e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MDM2—hematologic cancer	3.58e-06	4.12e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.58e-06	4.12e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MTOR—hematologic cancer	3.55e-06	4.09e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CB—hematologic cancer	3.55e-06	4.09e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.55e-06	4.09e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—FGF2—hematologic cancer	3.55e-06	4.09e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MTOR—hematologic cancer	3.55e-06	4.09e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	3.55e-06	4.09e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3R1—hematologic cancer	3.5e-06	4.04e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.49e-06	4.02e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CB—hematologic cancer	3.48e-06	4.01e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MTOR—hematologic cancer	3.48e-06	4.01e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—JAK2—hematologic cancer	3.41e-06	3.92e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—HRAS—hematologic cancer	3.39e-06	3.91e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	3.39e-06	3.9e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—PIK3CA—hematologic cancer	3.39e-06	3.9e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PTEN—hematologic cancer	3.34e-06	3.85e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—PIK3CA—hematologic cancer	3.34e-06	3.84e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CDKN1B—hematologic cancer	3.34e-06	3.84e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	3.33e-06	3.83e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MDM2—hematologic cancer	3.32e-06	3.83e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—HRAS—hematologic cancer	3.32e-06	3.83e-05	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—AKT1—hematologic cancer	3.3e-06	3.8e-05	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	3.29e-06	3.79e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.29e-06	3.79e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TP53—hematologic cancer	3.27e-06	3.77e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CASP3—hematologic cancer	3.27e-06	3.77e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CDKN1B—hematologic cancer	3.27e-06	3.76e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL2—hematologic cancer	3.26e-06	3.76e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CASP3—hematologic cancer	3.26e-06	3.76e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL2—hematologic cancer	3.26e-06	3.75e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—IL6—hematologic cancer	3.25e-06	3.74e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—IL6—hematologic cancer	3.24e-06	3.73e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—CREBBP—hematologic cancer	3.24e-06	3.73e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MTOR—hematologic cancer	3.23e-06	3.72e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CB—hematologic cancer	3.23e-06	3.72e-05	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	3.23e-06	3.72e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	3.2e-06	3.69e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL2—hematologic cancer	3.2e-06	3.68e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—EP300—hematologic cancer	3.19e-06	3.67e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCND1—hematologic cancer	3.18e-06	3.67e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	3.18e-06	3.66e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—JUN—hematologic cancer	3.18e-06	3.66e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCND1—hematologic cancer	3.18e-06	3.66e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—JUN—hematologic cancer	3.17e-06	3.65e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.15e-06	3.63e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PTEN—hematologic cancer	3.13e-06	3.61e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—HRAS—hematologic cancer	3.13e-06	3.61e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	3.12e-06	3.59e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—JUN—hematologic cancer	3.11e-06	3.58e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—HRAS—hematologic cancer	3.09e-06	3.56e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	3.08e-06	3.55e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	3.07e-06	3.54e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PTEN—hematologic cancer	3.07e-06	3.54e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.07e-06	3.53e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PTEN—hematologic cancer	3.07e-06	3.53e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.05e-06	3.51e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CDKN1B—hematologic cancer	3.04e-06	3.5e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—ALB—hematologic cancer	3.03e-06	3.49e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	3.01e-06	3.47e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	3.01e-06	3.46e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	3.01e-06	3.46e-05	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—AKT1—hematologic cancer	3e-06	3.46e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	3e-06	3.45e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IL6—hematologic cancer	3e-06	3.45e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	3e-06	3.45e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	2.99e-06	3.44e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—EP300—hematologic cancer	2.99e-06	3.44e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.98e-06	3.44e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	2.97e-06	3.43e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL2—hematologic cancer	2.97e-06	3.42e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	2.96e-06	3.4e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	2.94e-06	3.39e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	2.93e-06	3.38e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—EP300—hematologic cancer	2.93e-06	3.37e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—EP300—hematologic cancer	2.92e-06	3.37e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.9e-06	3.34e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.9e-06	3.34e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.9e-06	3.34e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	2.9e-06	3.33e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.89e-06	3.33e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—JUN—hematologic cancer	2.89e-06	3.33e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	2.87e-06	3.3e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ALB—hematologic cancer	2.85e-06	3.29e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SRC—hematologic cancer	2.85e-06	3.28e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SRC—hematologic cancer	2.84e-06	3.27e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	2.8e-06	3.23e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	2.79e-06	3.22e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	2.79e-06	3.21e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	2.77e-06	3.2e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	2.77e-06	3.19e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—AKT1—hematologic cancer	2.77e-06	3.18e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—STAT3—hematologic cancer	2.75e-06	3.16e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—STAT3—hematologic cancer	2.74e-06	3.16e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—NRAS—hematologic cancer	2.74e-06	3.16e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—NRAS—hematologic cancer	2.73e-06	3.15e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	2.73e-06	3.15e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.73e-06	3.14e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	2.73e-06	3.14e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	2.72e-06	3.13e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	2.69e-06	3.1e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	2.68e-06	3.09e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.67e-06	3.08e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EP300—hematologic cancer	2.67e-06	3.07e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	2.62e-06	3.02e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	2.62e-06	3.02e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SRC—hematologic cancer	2.59e-06	2.99e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	2.57e-06	2.96e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.56e-06	2.95e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MYC—hematologic cancer	2.55e-06	2.94e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MYC—hematologic cancer	2.55e-06	2.93e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	2.55e-06	2.93e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	2.54e-06	2.93e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	2.52e-06	2.91e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.52e-06	2.9e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	2.5e-06	2.88e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	2.5e-06	2.88e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	2.49e-06	2.87e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	2.49e-06	2.87e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	2.39e-06	2.75e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—KRAS—hematologic cancer	2.36e-06	2.72e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PIK3CA—hematologic cancer	2.36e-06	2.72e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—KRAS—hematologic cancer	2.35e-06	2.71e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MYC—hematologic cancer	2.32e-06	2.67e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	2.32e-06	2.67e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PTEN—hematologic cancer	2.31e-06	2.66e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	2.31e-06	2.66e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	2.21e-06	2.55e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—EP300—hematologic cancer	2.2e-06	2.54e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PTEN—hematologic cancer	2.18e-06	2.51e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	2.17e-06	2.5e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	2.16e-06	2.49e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.15e-06	2.48e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	2.15e-06	2.47e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	2.12e-06	2.44e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TP53—hematologic cancer	2.1e-06	2.41e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TP53—hematologic cancer	2.09e-06	2.41e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—EP300—hematologic cancer	2.08e-06	2.39e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	2.05e-06	2.36e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—HRAS—hematologic cancer	2e-06	2.31e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—HRAS—hematologic cancer	2e-06	2.3e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.99e-06	2.3e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	1.97e-06	2.27e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	1.96e-06	2.26e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—AKT1—hematologic cancer	1.93e-06	2.22e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL6—hematologic cancer	1.92e-06	2.21e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL6—hematologic cancer	1.91e-06	2.21e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TP53—hematologic cancer	1.91e-06	2.2e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.89e-06	2.18e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	1.88e-06	2.16e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ALB—hematologic cancer	1.87e-06	2.15e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	1.82e-06	2.1e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—AKT1—hematologic cancer	1.81e-06	2.08e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.79e-06	2.06e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—AKT1—hematologic cancer	1.77e-06	2.04e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.77e-06	2.03e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL6—hematologic cancer	1.75e-06	2.01e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	1.73e-06	2e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.65e-06	1.9e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.63e-06	1.88e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	1.61e-06	1.86e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.54e-06	1.77e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.42e-06	1.64e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—EP300—hematologic cancer	1.36e-06	1.56e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—AKT1—hematologic cancer	1.33e-06	1.53e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.26e-06	1.45e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1e-06	1.16e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—AKT1—hematologic cancer	8.21e-07	9.45e-06	CbGpPWpGaD
